← Back to Search

Robotics

Robot-Assisted Stroke Rehabilitation for Stroke (Baxter Trial)

N/A
Waitlist Available
Led By Michelle J Johnson, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 session, about 2 hours in length
Awards & highlights

Baxter Trial Summary

This trial will test if a humanoid robot can interact with a patient in a more intuitive and flexible way, while also investigating the safety of contact and release.

Eligible Conditions
  • Stroke
  • Hemiplegia
  • Healthy Subjects

Baxter Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 session, about 2 hours in length
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 session, about 2 hours in length for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-Therapist Interaction Mapping

Baxter Trial Design

1Treatment groups
Experimental Treatment
Group I: Stroke survivors and healthy subjectsExperimental Treatment1 Intervention
Stroke survivors greater than 18 years of age with hemiplegia and varying levels of impairment as well as healthy subjects greater than 18 years old with no motor disabilities will be asked to interact with a therapist. The Patient-Therapist interactions will be recorded using the Rehab Intercap System and 3D Kinect Device.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,880,023 Total Patients Enrolled
29 Trials studying Stroke
2,136 Patients Enrolled for Stroke
Michelle J Johnson, PhDPrincipal InvestigatorPenn Medicine Rittenhouse
11 Previous Clinical Trials
1,996 Total Patients Enrolled
9 Trials studying Stroke
243 Patients Enrolled for Stroke

Media Library

Rehab InterCap system and 3D Kinect (Robotics) Clinical Trial Eligibility Overview. Trial Name: NCT02806843 — N/A
Stroke Research Study Groups: Stroke survivors and healthy subjects
Stroke Clinical Trial 2023: Rehab InterCap system and 3D Kinect Highlights & Side Effects. Trial Name: NCT02806843 — N/A
Rehab InterCap system and 3D Kinect (Robotics) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02806843 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this clinical trial still underway?

"The details specified on the clinicaltrials.gov website signify that this medical trial is not presently accepting participants; it was published on May 1st 2014 and amended most recently on September 6th 2022. Despite this, there are a plethora of other studies actively recruiting at present – 1894 in total."

Answered by AI

Who else is applying?

What state do they live in?
California
Pennsylvania
What site did they apply to?
Penn Medicine Rittenhouse
What portion of applicants met pre-screening criteria?
Did not meet criteria
~4 spots leftby Dec 2024